-transparent.png){kind=logo}
The pattern of development of the granulocyte/macrophage progenitor cell (GM-CFC) pools in the course of canine ontogeny was studied by means of the agar culture technique. Colony formation was stimulated by colony stimulating activity (CSA) in serum from lethally irradiated dogs in combination with erythrocyte-depleted peripheral blood leukocytes from normal adult dogs. The colonies thus obtained in cultures from the different organs were in general large (estimated maximum 50 000 cells) and consisted predominantly of mononucleated macrophages, suggesting that, in these studies, a progenitor cell with high proliferative potential (HPP-CFC) has been monitored. In the yolk sac, a transitory GM-CFC pool became established between day 23 and day 48 of gestation, reaching maximum numbers of approximately 41 X 10(3) per organ on days 36/37. At the same time the GM-CFC concentration in blood collected from the heart also reached a maximum of about 31 X 10(3)/ml, indicating its carrier function for the migration of GM-CFC. In the liver a quasi-exponential increase in the GM-CFC numbers took place between days 36/37 and days 57 to 59 when a total of about 15.2 X 10(6) was found but thereafter and up to day 4 post partum the GM-CFC numbers decreased by almost two orders of magnitude. A continuous increase in the GM-CFC numbers was found in the spleen between day 42 of gestation and day 4 post partum when a maximum of 5.1 X 10(6) to 8.7 X 10(6) was reached. In contrast to the GM-CFC numbers in the liver, the splenic GM-CFC dropped only by 50% of peak values when the dogs reached adulthood. The bone marrow always had the highest incidence of GM-CFC, the concentration per 10(6) cells being 18.7 X 10(3)/10(6) cells on days 45/46, the earliest time point at which cultures could be set up. The absolute GM-CFC numbers in the two femora increased continuously between days 45/46 and day 4 post partum in parallel with the growth of the bones. In the thymus a relatively small population of GM-CFC developed between days 42 and 48 of gestation that was kept quite constant at average numbers between 13 X 10(3) and 30 X 10(3) up to day 4 post partum.
W Nothdurft, and
E Braasch, and
W Calvo, and
O Prümmer, and
F Carbonell, and
G Grilli, and
T M Fliedner
February 1988,
European journal of haematology,
W Nothdurft, and
E Braasch, and
W Calvo, and
O Prümmer, and
F Carbonell, and
G Grilli, and
T M Fliedner
August 1987,
European journal of haematology,
W Nothdurft, and
E Braasch, and
W Calvo, and
O Prümmer, and
F Carbonell, and
G Grilli, and
T M Fliedner
September 1985,
Experimental hematology,
W Nothdurft, and
E Braasch, and
W Calvo, and
O Prümmer, and
F Carbonell, and
G Grilli, and
T M Fliedner
May 1984,
Radiation research,
W Nothdurft, and
E Braasch, and
W Calvo, and
O Prümmer, and
F Carbonell, and
G Grilli, and
T M Fliedner
June 1983,
International journal of cell cloning,
W Nothdurft, and
E Braasch, and
W Calvo, and
O Prümmer, and
F Carbonell, and
G Grilli, and
T M Fliedner
January 1985,
Leukemia research,
W Nothdurft, and
E Braasch, and
W Calvo, and
O Prümmer, and
F Carbonell, and
G Grilli, and
T M Fliedner
January 1992,
International journal of radiation oncology, biology, physics,
W Nothdurft, and
E Braasch, and
W Calvo, and
O Prümmer, and
F Carbonell, and
G Grilli, and
T M Fliedner
June 1986,
International journal of radiation oncology, biology, physics,
W Nothdurft, and
E Braasch, and
W Calvo, and
O Prümmer, and
F Carbonell, and
G Grilli, and
T M Fliedner
November 1981,
British journal of haematology,
W Nothdurft, and
E Braasch, and
W Calvo, and
O Prümmer, and
F Carbonell, and
G Grilli, and
T M Fliedner
November 1987,
Cancer letters,
